Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In humans, NK receptors are expressed by natural killer cells and some T cells, the latter of which are preferentially alphabetaTCR+ CD8+ cytolytic T lymphocytes (CTL). In this study we analyzed the expression of nine NK receptors (p58.1, p58.2, p70, p140, ILT2, NKRP1A, ZIN176, CD94 and CD94/NKG2A) in PBL from both healthy donors and melanoma patients. The percentages of NK receptor-positive T cells (NKT cells) varied strongly, and this variation was more important between individual patients than between individual healthy donors. In all the individuals, the NKT cells were preferentially CD28-, and a significant correlation was found between the percentage of CD28- T cells and the percentage of NK receptor+ T cells. Based on these data and the known activated phenotype of CD28- T cells, we propose that the CD28- CD8+ T cell pool represents or contains the currently active CTL population, and that the frequent expression of NK receptors reflects regulatory mechanisms modulating the extent of CTL effector function. Preliminary results indicate that some tumor antigen-specific T cells may indeed be CD28- and express NK receptors in vivo.

Original publication

DOI

10.1002/(SICI)1521-4141(199906)29:06<1990::AID-IMMU1990>3.0.CO;2-9

Type

Journal article

Journal

Eur J Immunol

Publication Date

06/1999

Volume

29

Pages

1990 - 1999

Keywords

Adult, Aged, Amino Acid Sequence, Antigens, CD, Antigens, CD28, Antigens, Neoplasm, CD8-Positive T-Lymphocytes, Case-Control Studies, Female, Fetal Blood, Humans, Infant, Newborn, Killer Cells, Natural, Lymphocyte Count, Male, Melanoma, Middle Aged, Receptors, Antigen, T-Cell, alpha-beta, Receptors, Immunologic, T-Lymphocytes, Cytotoxic